Taken together, these data suggest that ALS-associated C-terminal mutations impair the ability of ANXA11 to associate with lysosomes, and both C- and N-terminal mutations impact properties of ANXA11 within phase-separated structures. This evidence concerns the gene ANXA11 and amyotrophic lateral sclerosis.